Natural Hair (UK) Diane 35, dianette, cyproterone acetate, adrogenetic alopecia women Natural-Hair - Alopecia and Hair loss resource center.- Diane 35 for female pattern baldness or androgenetic alopecia in women

Natural Hair (UK)Frequently Asked Questions
Links to other SitesPrivacy Policy

Search ....  

US SITE
View your shopping cart

Dutas
Propecia
Proscar
Regaine 5%
Headway
Nizoral Shampoo
Prostaguard
Retin-A
Skinoren
Pill Cutter


Hairloss information and resources
provided
by Natural-Hair

Hair Structure and Life Cycle
Common Types of Hair Loss
Alopecia Areata
Androgenetic Alopecia
Anagen Effluvium
Self Induced Hair Loss
Scarring Alopecia
Other Types of Hair Loss
Hair Loss Treatments
Medical Treatments for Androgenetic Alopecia
Natural Treatments for Androgenetic Alopecia
Alopecia Areata Treatments
Glossary of terms
Links to other sites
E-mail Enquiries/ Comments
        
Home Inhouse Drugstore
 
 
  Diane 35 (Cyproterone Acetate with Ethinyloestradiol)

Diane 35 is a hormonal contraceptive tablet that is prescribed for the treatment of severe acne and hursuitism in woman and for female pattern baldness or androgenetic alopecia in women. The aim of treatment with Diane 35 is to block the peripheral action of male hormones commonly present in the female body. It is possible for treatment to halt further hair loss and increase hair thickness within about a year. However this treatment needs to be continued long term in order to maintain the effect. Possible side effects include breast tenderness, headaches and decreased libido. One beneficial side effect is the Diane 35 helps prevent Osteoporosis.

Studies involving Diane 35

STUDY: Ovarian suppression with Diane 35/50

STUDY: Treatment of moderately severe virilism of women with Diane and Androcur 10

STUDY: Contraception in androgenised women with a low-dose cyproterone-acetate containing one-phase preparation

STUDY: Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia

STUDY: Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms

STUDY: Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female